• According to Transparency Market Research’s latest report on the Global Cardiac Biomarker Diagnostic Kits market for the historical period 2017–2018 and forecast period 2019–2027, rising prevalence of cardiovascular disorders across the globe and advancements in novel technologies are projected to drive the global cardiac biomarker diagnostic kits market during the forecast period
  • According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2018 and is anticipated to grow at a CAGR of 5.2% from 2019 to 2027

Request a sample to get extensive insights into the Cardiac Biomarker Diagnostic Kits Market

Rising prevalence of cardiovascular diseases across the globe : Key Driver

  • Growing prevalence of cardiovascular disorders across the globe is a key factor driving the global cardiac biomarker diagnostic kits market.
  • For instance, as per World Health Organization (WHO), every year around 17.9 million people die due to cardiovascular diseases globally which constitutes an estimated 31% of all deaths worldwide.
  • Advancements and technological innovations prompt patients to opt for easy-to-use and portable medical devices, which is also fuelling the growth of global cardiac biomarker diagnostic kits market
  • Moreover, rising government funding for cardiovascular disease treatment, early detection to track the heart condition, and integration of cardiology & IT are also some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market

To understand how our report can bring difference to your business strategy, Ask for a brochure

Lack of trained staff and appropriate health care infrastructure in developing economies hamper the market growth

  • A cardiac biomarker involves various technical skills, which require appropriate training to handle the device. Sometimes, hospitals or people from developing countries lack awareness about the biomarker and its handling. It creates a barrier between the manufacturing of the device and usage, thereby restraining the market
  • Also Lack of awareness in developing countries and Negative impact of economic constraint in certain regions & pricing pressure can restrain the global market  growth

Global Cardiac Biomarker Diagnostic Kits Market: North America dominated the global market

  • On the basis of region, the cardiac biomarker diagnostic kits market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
  • North America region is accounted for major market share in the global market owing to higher patient population for cardiac diseases, expansion of high-sensitive cardiac biomarkers, rise in acceptance of point-of-care instruments by hospitals and clinics, advancements in technology, and development of high sensitivity POC testing in the region
  • However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly attributed to developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region

Stuck in a neck-to-neck competition with other brands? Request a custom report on Cardiac Biomarker Diagnostic Kits Market

Global Cardiac Biomarker Diagnostic Kits Market: Competitive Landscape

  • This report profiles major players in the global cardiac biomarker diagnostic kits market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiac biomarker diagnostic kits market is highly consolidated, with a few global players accounting for a major share in market.
  • Leading players operating in the global Cardiac biomarker diagnostic kits market are
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Siemens Healthineers
    • bioMérieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • among others

Global Cardiac Biomarker Diagnostic Kits Market: Key Developments

Key players in the global cardiac biomarker diagnostic kits market are engaged in regulatory approvals, new product development, technological advancements, merger, acquisitions & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cardiac biomarker diagnostic kits market. A few expansion strategies adopted by players operating in the global Cardiac biomarker diagnostic kits market are:

  • In April 2019, US FDA has approved Ortho Clinical Diagnostics VITROS XT MicroSlides which features new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide
  • In September 2018, Abbott receives CE Mark for first troponin test to help predict the chance of heart attack in apparently healthy adults potentially months to years in advance.

 The report on the global cardiac biomarker diagnostic kits market discussed individual strategies, followed by company profiles of manufacturers of cardiac biomarker diagnostic kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiac biomarker diagnostic kits market

Global Cardiac Biomarker Diagnostic Kits market - Scope of Report

TMR’s report on the global cardiac biomarker diagnostic kits market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cardiac biomarker diagnostic kits market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiac biomarker diagnostic kits market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiac biomarker diagnostic kits market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiac biomarker diagnostic kits market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cardiac biomarker diagnostic kits market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiac biomarker diagnostic kits market.

The report delves into the competitive landscape of the global cardiac biomarker diagnostic kits market. Key players operating in the global cardiac biomarker diagnostic kits market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiac biomarker diagnostic kits market that have been profiled in this report.

Key Questions Answered in Global Cardiac biomarker diagnostic kits market Report

  • What is the scope of growth of product companies in the global cardiac biomarker diagnostic kits market?
  • What will be the Y-o-Y growth of the global cardiac biomarker diagnostic kits market between 2019 and 2027?
  • What is the influence of changing trends in changing technologies on the global cardiac biomarker diagnostic kits market?
  • Will North America continue to be the most profitable market for cardiac biomarker diagnostic kits providers?
  • Which factors are anticipated to hamper the growth of the global cardiac biomarker diagnostic kits market during the forecast period?
  • Which are the leading companies in the global cardiac biomarker diagnostic kits market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cardiac biomarker diagnostic kits market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global cardiac biomarker diagnostic kits market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the Cardiac biomarker diagnostic kits market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cardiac biomarker diagnostic kits market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cardiac biomarker diagnostic kits market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global Cardiac biomarker diagnostic kits market more reliably and accurately.

Regional Segmentation of Cardiac biomarker diagnostic kits market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Cardiac biomarker diagnostic kits market - Segmentation 

Product

  • Troponin Test Kits
  • CK-MB Test Kits
  • Myoglobin Test Kits
  • BNP Test Kits
  • C-reactive Protein (hsCRP)
  • Other Biomarkers

Application

  • Angina Pectoris
  • Myocardial Infarction (MI)
  • Cardiac Heart Failure
  • Others

Testing

  • Laboratory Testing
  • Point-of-care Testing

End-user

  • Hospitals
  • Clinics
  • Diagnostic Laboratory

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cardiac Biomarker Diagnostic Kits Market

Buy Now